BAKER BROS ADVISORS LLC Insider Trading $NTLA Intellia Therapeutics, Inc.
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in Intellia Therapeutics, Inc.
Trading Symbol: NTLAIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAKER BROS ADVISORS LLC:
Holdings: 976,214 shares
Current Value: $12,983,646
Latest Transaction: May 11 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in Intellia Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 1,232,130 | 0 | 0 | ||
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Option Exercise | C | 0.00 | 101,204 | 0 | 0 | ||
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Buy | P | 18.00 | 179,531 | 3,231,558 | 976,214 | 796.7 K to 976.2 K (+22.53 %) | |
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Buy | P | 18.00 | 20,469 | 368,442 | 85,906 | 65.4 K to 85.9 K (+31.28 %) | |
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Buy | C | 0.00 | 796,683 | 0 | 796,683 | 0 to 796.7 K | |
May 11 2016 | NTLA | Intellia Therapeut ... | BAKER BROS. ADVISORS LP | Buy | C | 0.00 | 65,437 | 0 | 65,437 | 0 to 65.4 K |
Page: 1